NCT03112538 - Improving Glycaemic Control in Malaysian Patients With Type 2 Diabetes Mellitus With Insulin Pump Therapy | Biotech Hunter

Enrollment

118

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions

Type 2 Diabetes Mellitus

Interventions

DEVICE

Insulin Pump

Medtronic Minimed Paradigm Veo Insulin Pump

DRUG

Multiple daily injections of insulin

Multiple daily injections which consist of a single injection of basal insulin(insulin Glargine) and 3 injections of bolus insulin(rapid acting insulin Glulisine or Aspart) before each meal

Trial Locations (1)

62250

RECRUITING

Hospital Putrajaya, Putrajaya